Font Size: a A A
Keyword [TKIs]
Result: 121 - 140 | Page: 7 of 10
121. The Study Of The Mechanism Of Yiqi Chutan Tang In Intervention Of EGFR-TKIs Acquired Drug Resistance In Lung Cancer
122. Mechanisms Of Hedgehog Signaling Pathway To Acquire EGFR-TKIs Resistance In EGFR-mutated Non-small Cell Lung Cancer Patients With Brain Metastasis
123. Study The Effects And Mechanisms Of IL-7 On Bone Marrow Mesenchymal Stromal Cells Promoting Drug Resistance Of Chronic Myeloid Leukemia Cells To TKIs
124. Investigation On The Anti-tumor Efficacy And Mechanisms Of Small Molecule Kinase Inhibitors In Non-small Cell Lung Cancer
125. The Effects Of EGFR-TKIs And Sanguinarine On MHC-? In NSCLC And The Possible Mechanism
126. Cytoplasmic P120ctn Promotes Tyrosine Kinase Inhibitor Resistance In Lung Cancer Cells By Activating PAKs And Mediated EGFR Downstream Activation
127. The Efficacy Of EGFR-TKIs In The Patients With Advanced Non-small Cell Lung Cancer By Poor Performance Status:A Meta-analysis
128. Clinical And Genetic Factors Affecting The Efficacy Of Chronic Myeloid Leukemia In TKIs Era
129. Expression Of EGFR Gene And Ki-67 Protein In Lung Adenocarcinoma With Micropapillary Structure And Its Clinical Relevance
130. Relationship Between EGFR Gene Expression And Radiosensitivity In Egfr-mutant NSCLC Cell Line
131. Therapy Response To EGFR-TKI In Elderly And Young Patients With NSCLC: A Systematic Review And Meta-analysis
132. Effect And Safety Analysis Of EGFR-TKIs Combined With Radiotherapy In The Treatment Of Brain Metastases Of Non Small Cell Lung Cancer
133. Demographic Characteristics Of Chinese Lung Adenocarcinoma Patients With EGFR Mutation And Primary Resistant Mechanisms To EGFR-TKIs
134. Treatment And Outcome Of Advanced NSCLC With Known EGFR Status In The Real World
135. MiR-625-3p Modulates Gefitinib Resistance Through AXL In Non-small Cell Lung Cancer
136. A Research On Antitumor Activities And Molecular Mechanisms Of EGFR-TKIs In Esophageal Squamous Cell Carcinoma
137. Design,Synthesis And Anti-tumor Activity Of Quinazoline Compounds And Analogues Targeting Epidermal Growth Factor Receptor
138. The Study Of ?-Elemene's Effect On Patients With Advanced Non-small Cell Lung Caner After Slow Progression On The First Generation Of EGFR-TKIs
139. Three New Disease-progression Modes In NSCLC Patients After EGFR-TKIs Treatment By Next-Generation Sequencing Analysis
140. Different Mutation Subtypes Of 19del Indicate Distinct Response To EGFR-TKIs Treatment In Advanced Lung Adenocarcinoma
  <<First  <Prev  Next>  Last>>  Jump to